Lakshmipriya Nair

Selumetinib did not meet trial endpoint of progression-free survival in KRASm NSCLC patients AstraZeneca has announced results…

Company registered a 60 per cent increase in net profits for the first quarter Morepen Laboratories has reported a 60 per cent…

Net sales for the quarter came in at Rs 685 crores, recording a growth of eight per cent GlaxoSmithKline Pharmaceuticals declared…

First IL-23p19 antibody to meet primary endpoints in pivotal phase-3 clinical trials in patients with moderate-to-severe plaque…

It has also entered into collaboration with Biophore for the development of niche products for the US market RPG Life Sciences has…

Trade agreements and pressure on India pose major threats to access Doctors Without Borders/Médecins Sans Frontières (MSF)…

The proposed biosimilar is used to reduce the duration of neutropenia and the incidence of febrile neutropenia in adult patients…

Titled 'Voices from TB', it tells the stories of TB survivors in India Lilly MDR-TB partnership has released of a compilation of…

These tablets are therapeutic equivalents of IPR Pharmaceuticals' Crestor Sun Pharma has announced that one of its subsidiaries…

Developed by Sun Pharma’s R&D team in India, InfuSMART will be rolled out across six countries - Netherlands, UK, Spain,…